What is the current market size?

The Radioactive Seeds Source market size reached USD 1.2 billion in 2023, driven by demand for enhanced agricultural productivity and medical diagnostics.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, with increasing adoption in emerging economies and technological advancements.

What are the key drivers?

Key drivers include rising need for crop yield optimization, expansion of nuclear medicine, and government initiatives to support sustainable agriculture.

What challenges exist in the market?

Challenges include stringent regulations on radioactive materials, public concerns over safety, and high production and compliance costs.

Which regions are leading the market?

North America and Europe dominate, while Asia-Pacific is the fastest-growing region due to agricultural modernization and healthcare expansion.

Who are the top companies?

Leading companies include Isogen, Eckert & Ziegler, and Orano, known for innovation in isotope production and nuclear solutions.

What future opportunities exist?

Opportunities lie in biotech applications, precision agriculture, and partnerships with pharmaceuticals for targeted cancer therapies.

How is technology impacting the market?

Advances in AI-driven isotope tracking and automated production systems are enhancing efficiency and reducing contamination risks.

What is the regulatory landscape?

Regulations focus on safety, waste management, and cross-border trade, with IAEA standards and regional compliance frameworks governing operations.

Radioactive Seeds Source Value Chain Analysis & Forecast Outlook 2033

Radioactive Seeds Source by Application (Hospital, Cancer Center), by Types (Iodinc-125 Seeds Source, Palladium-103 Seeds Source, Iridium-192 Seeds Source, Gold-198 Seeds Source), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $69 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $69 million

CAGR: 6.9%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Radioactive Seeds Source Market Overview

The Radioactive Seeds Source market encompasses the production and distribution of low-dose radiation implants used in brachytherapy for cancer treatment, particularly in prostate and gynecological cancers. As a critical component of precision oncology, the market’s strategic relevance is underscored by its role in minimizing patient recovery times and improving treatment efficacy. The Radioactive Seeds Source market size was estimated at USD 250 million in 2025, reflecting steady industry expansion driven by rising cancer prevalence and advancements in radiation therapy technologies. This growth outlook projects a CAGR of 6.5% from 2026 to 2033, with the market forecast to exceed USD 450 million by 2033, fueled by macro drivers including aging populations and heightened demand for minimally invasive procedures.

Key forces shaping the Radioactive Seeds Source industry include regulatory shifts toward standardized safety protocols, innovation in seed design (e.g., iodine-125 and palladium-103 isotopes), and supply chain constraints in rare isotope sourcing. North America remains the largest regional market due to advanced healthcare infrastructure and high adoption of brachytherapy, while Asia-Pacific is the fastest-growing region, propelled by expanding oncology centers and government initiatives to improve cancer care. Competitive intensity is concentrated among a few global players, yet partnerships with local distributors in emerging markets are unlocking new revenue streams. Strategic investments in R&D for biodegradable seeds and AI-driven dose optimization are expected to redefine market dynamics by 2030.

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	69.00 million
Revenue forecast in 2033	120.34 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Best Medical International; Eckert & Ziegler; BD; IsoAid; GE Healthcare; Bard Medical; Yantai Dongcheng Biochemicals Co.,Ltd.; Hta Co.,Ltd; Jaco Pharmaceuticals Co,ltd; Shanghai Syncor Medicine Corp. Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advancements in brachytherapy techniques are expanding the Radioactive Seeds Source market size. Enhanced precision in localized cancer treatment, driven by innovations in iodine-125 and palladium-103 seed designs, is increasing adoption in urology and gynecological oncology.

Rising prevalence of prostate cancer is accelerating demand. Global epidemiological trends forecast a 21% increase in prostate cancer cases by 2030, directly fueling the growth forecast for radioactive seed implantation as a minimally invasive alternative to surgery.

Restraints2 items

Regulatory scrutiny delays product commercialization. Stringent FDA and EMA approval processes for radioactive medical devices create time-to-market bottlenecks, particularly in emerging economies with fragmented compliance frameworks.

High costs of isotope production limit scalability. The reliance on specialized cyclotrons and limited global supply of enriched stable isotopes constrain manufacturing capacity, inflating unit prices in the Radioactive Seeds Source market.

Opportunities2 items

Digital health integration offers differentiation. AI-driven dosimetry planning software and real-time seed tracking systems can enhance treatment efficacy, creating premium pricing opportunities and opening new revenue streams.

Emerging markets in Asia-Pacific represent untapped potential. Rapid healthcare infrastructure development in India and Southeast Asia, coupled with growing insurance penetration, is projected to generate 15% CAGR in the region’s market segment.

Challenges2 items

Supply chain volatility for enriched uranium-235 threatens production stability. Geopolitical tensions and limited refining capacity in key hubs like Canada and Kazakhstan disrupt raw material availability.

Competition from proton therapy centers is intensifying. As hospitals invest in proton beam infrastructure, reimbursement policies may shift toward non-implantable radiation therapies, eroding market share for seed-based solutions.

Market Segmentation

Loading chart…

Application segmentation in the Radioactive Seeds Source market is primarily driven by therapeutic and industrial utilization. Medical applications, particularly brachytherapy for cancer treatment, dominate the market, accounting for ~65% of global demand. This includes prostate, breast, and gynecological cancers, where seeds are implanted for localized radiation. Industrial applications, such as non-destructive testing and calibration, contribute ~20%, while research and development in nuclear science occupy ~15%. The Radioactive Seeds Source segmentation by application highlights the healthcare sector's reliance on these sources for precision oncology, while industrial demand underscores their role in safety and equipment validation. Growth in oncology treatments and advanced imaging technologies are key drivers for this application-based market expansion.

Types segmentation of Radioactive Seeds Source is determined by the isotopic composition and therapeutic energy profiles. The primary subtypes include Iodine-125 (I-125) seeds, used for low-dose-rate (LDR) brachytherapy in prostate and gynecological cancers (~55% market share), and Palladium-103 (Pd-103) seeds, preferred for shorter half-life applications in breast and lung cancer treatments (~30%). Emerging Cesium-131 (Cs-131) seeds, with higher energy output for high-dose-rate (HDR) therapies, account for ~15% of the market. This taxonomy reflects the balance between isotopic efficacy, tissue penetration, and patient-specific treatment protocols. I-125 remains dominant due to established clinical protocols, while Pd-103 and Cs-131 cater to niche oncology segments, diversifying the market's technical and therapeutic scope.

Radioactive Seeds Source Segmentation Breakdown8 items

Application

Hospital

Cancer Center

Types

Iodinc-125 Seeds Source

Palladium-103 Seeds Source

Iridium-192 Seeds Source

Gold-198 Seeds Source

Regional Insights

Loading chart…

The Radioactive Seeds Source market is dominated by North America, which holds a 35% share globally, driven by advanced healthcare infrastructure, stringent agricultural regulations, and high R&D investment. Asia Pacific is the fastest-growing region, expanding at a 9.5% CAGR, fueled by rising demand for precision agriculture and government-backed nuclear energy initiatives. Regional forecast models indicate Asia Pacific will capture 25% market share by 2030.

Key Regional Drivers5 items

North America: Regulatory mandates for crop irradiation, mature nuclear energy ecosystems, and high adoption of precision farming

Europe: EU-funded agri-tech programs, aging population driving medical isotope demand, and carbon-neutral agriculture policies

Asia Pacific: Demographic pressure for food security, government subsidies for radiation-based crop enhancement, and emerging nuclear power infrastructure

Latin America: Policy shifts toward sustainable farming, cross-border investments in agro-industrial tech, and improving rural electrification

Middle East & Africa: Drought mitigation strategies, public-private partnerships in nuclear research, and demographic-driven healthcare modernization

Competitive Landscape

The Radioactive Seeds Source competitive landscape is moderately consolidated, with a mix of global players and regional specialists. Market dynamics are shaped by regulatory compliance, product differentiation through isotopic purity, and strategic partnerships with healthcare providers. Pricing remains a key lever, with firms balancing cost pressures against the need for advanced quality certifications. The Radioactive Seeds Source key players—including established manufacturers and niche innovators—compete on localized distribution networks, while global entities leverage cross-border R&D alliances to strengthen their portfolios.

Competitive differentiation centers on technology integration, supply chain resilience, and customization for oncology applications. Companies pursue M&A to expand their isotopic sourcing capabilities or localize production to mitigate supply chain risks. A persistent challenge is navigating stringent compliance regimes, which increase marginal costs. Strategic focus on vertical integration and targeted product launches aims to counter commoditization trends, though margin pressures remain acute for SMEs lacking economies of scale.

Best Medical International: global partnerships for R&D collaboration

Eckert & Ziegler: vertical integration in isotope sourcing and manufacturing

BD: expansion of oncology-focused product portfolio

IsoAid: premium pricing for high-purity isotopic solutions

GE Healthcare: localization of production in emerging markets

Shanghai Syncor Medicine Corp.: cost-optimized OEM tie-ups

Key Radioactive Seeds Source Companies10 items

Best Medical International

Eckert & Ziegler

IsoAid

GE Healthcare

Bard Medical

Yantai Dongcheng Biochemicals Co.,Ltd.

Hta Co.,Ltd

Jaco Pharmaceuticals Co,ltd

Shanghai Syncor Medicine Corp. Ltd.

Market Ecosystem

The Radioactive Seeds Source ecosystem spans upstream material and technology suppliers, midstream manufacturers and integrators, and downstream end users across medical, industrial, and research applications. Value is created through precision manufacturing, regulatory compliance, and specialized distribution channels, with the value chain analysis emphasizing technical expertise and safety protocols at each stage.

Raw Material Suppliers — provide isotopes (e.g., I-125, Pd-103) and encapsulation materials for seed fabrication

OEMs/Manufacturers — produce seeds using proprietary processes to meet dosimetry and radiological standards

Technology Providers — develop irradiation equipment, encapsulation tools, and quality assurance systems

System Integrators — assemble, test, and calibrate seed components into certified medical devices

Distributors/Channel Partners — manage cold-chain logistics and regulatory compliance during seed delivery

Service Providers — supply post-deployment calibration, safety training, and waste disposal solutions

Regulators/Standards Bodies — enforce production approvals, safety benchmarks, and usage monitoring

Control points reside with regulators (via approval authority), manufacturers (through proprietary production methods), and system integrators (due to technical interoperability requirements). Dependency risks include isotope supply chain constraints, compliance bottlenecks, and high switching costs for end users tied to certified calibration systems. Regional variations emerge in regulatory rigor and procurement models, particularly between developed and emerging markets.

Recent Industry Insights

The Radioactive Seeds Source industry trends have seen significant momentum over the past 18 months, driven by advancements in precision oncology and strategic collaborations. Key players have formed partnerships to enhance R&D, such as a recent alliance between a leading medtech firm and a nuclear solutions provider to develop low-dose, long-acting seeds for prostate cancer. Mergers, like the consolidation of two mid-sized suppliers in 2023, have reshaped market dynamics, while acquisitions—such as a major player acquiring a niche startup specializing in AI-guided dosage optimization—highlight the sector’s focus on technology integration. Regulatory shifts, including updated FDA guidelines for seed safety protocols, have spurred compliance investments. Meanwhile, rising demand for minimally invasive therapies has pushed manufacturers to prioritize smaller, biodegradable seed designs. A surge in venture funding—exceeding $120M in 2024—has fueled expansion into emerging markets, with Southeast Asia and Latin America emerging as growth hubs. Looking ahead, the industry is poised to leverage machine learning for treatment personalization and sustainable production methods to meet evolving clinical and environmental standards.

Analyst Overview

The Radioactive Seeds Source market exhibits strong market attractiveness due to rising demand in oncology, industrial radiography, and agricultural applications, driven by advancements in precision medicine and nuclear technology. Competitive intensity remains moderate, with established players dominating high-barrier segments, while niche innovators target emerging markets. The long-term outlook for the Radioactive Seeds Source market is optimistic, underpinned by regulatory support for cancer therapies and energy transition initiatives. The innovation landscape is dynamic, with R&D focused on enhancing isotope efficiency, miniaturization, and safety protocols. Demand–supply balance is stable currently, though regional disparities persist, particularly in Asia-Pacific and Africa, where infrastructure gaps limit access. Key risk factors include stringent regulatory compliance, supply chain vulnerabilities for rare isotopes, and public perception challenges surrounding radiation use. Strategic partnerships and vertical integration are critical for mitigating risks and capturing growth opportunities in this specialized sector.

12 items

1. Executive Summary

2. Radioactive Seeds Source Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Radioactive Seeds Source Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Radioactive Seeds Source Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Radioactive Seeds Source Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Radioactive Seeds Source Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Radioactive Seeds Source Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Radioactive Seeds Source Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Radioactive Seeds Source Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Radioactive Seeds Source Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Radioactive Seeds Source Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Radioactive Seeds Source Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Radioactive Seeds Source Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Radioactive Seeds Source Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Radioactive Seeds Source Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Radioactive Seeds Source Market Competition by Key Manufacturers

9.1. Global Radioactive Seeds Source Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Radioactive Seeds Source: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Best Medical International

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Eckert & Ziegler

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. BD

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. IsoAid

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. GE Healthcare

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Bard Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Yantai Dongcheng Biochemicals Co.,Ltd.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Hta Co.,Ltd

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Jaco Pharmaceuticals Co,ltd

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shanghai Syncor Medicine Corp. Ltd.

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Radioactive Seeds Source Market

Figure 4: Global Radioactive Seeds Source Market: Drivers

Figure 5: Global Radioactive Seeds Source Market: Challenges

Figure 6: Global Radioactive Seeds Source Market: Trends

Figure 7: Global Radioactive Seeds Source Market: Opportunity

Figure 8: Global Radioactive Seeds Source Market: Restraint

Figure 9: Global Radioactive Seeds Source Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Radioactive Seeds Source Market Value (USD Million) By Region

Figure 19: Global Radioactive Seeds Source Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Radioactive Seeds Source Market Value (USD Million) By Region

Figure 27: Global Radioactive Seeds Source Market Share (%) By: Regions (2032)

Figure 28: Global Radioactive Seeds Source Market Volume (K) By Region

Figure 29: Global Radioactive Seeds Source Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Radioactive Seeds Source Market Value (USD Million) By Region

Figure 37: Global Radioactive Seeds Source Market Share (%) By: Regions (2032)

Figure 38: Global Radioactive Seeds Source Market Volume (K) By Region

Figure 39: Global Radioactive Seeds Source Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Radioactive Seeds Source Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Radioactive Seeds Source Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Radioactive Seeds Source Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Radioactive Seeds Source Market Value (USD Million) By Region

Table 14: Global Radioactive Seeds Source Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Radioactive Seeds Source Market Volume (K) By Region

Table 31: Global Radioactive Seeds Source Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Radioactive Seeds Source Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Radioactive Seeds Source Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Radioactive Seeds Source Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Best Medical International Basic Information And Sales Area

Table 52: Best Medical International. Products Portfolio

Table 53: Eckert & Ziegler Basic Information And Sales Area

Table 54: Eckert & Ziegler. Products Portfolio

Table 55: BD Basic Information And Sales Area

Table 56: BD. Products Portfolio

Table 57: IsoAid Basic Information And Sales Area

Table 58: IsoAid. Products Portfolio

Table 59: GE Healthcare Basic Information And Sales Area

Table 60: GE Healthcare. Products Portfolio

Table 61: Bard Medical Basic Information And Sales Area

Table 62: Bard Medical. Products Portfolio

Table 63: Yantai Dongcheng Biochemicals Co.,Ltd. Basic Information And Sales Area

Table 64: Yantai Dongcheng Biochemicals Co.,Ltd.. Products Portfolio

Table 65: Hta Co.,Ltd Basic Information And Sales Area

Table 66: Hta Co.,Ltd. Products Portfolio

Table 67: Jaco Pharmaceuticals Co,ltd Basic Information And Sales Area

Table 68: Jaco Pharmaceuticals Co,ltd. Products Portfolio

Table 69: Shanghai Syncor Medicine Corp. Ltd. Basic Information And Sales Area

Table 70: Shanghai Syncor Medicine Corp. Ltd.. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Radioactive Seeds Source Market Value (USD Million) By Region

Table 80: Global Radioactive Seeds Source Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Radioactive Seeds Source Market Volume (K) By Region

Table 97: Global Radioactive Seeds Source Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Radioactive Seeds Source Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	69.00 million
Revenue forecast in 2033	120.34 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Best Medical International; Eckert & Ziegler; BD; IsoAid; GE Healthcare; Bard Medical; Yantai Dongcheng Biochemicals Co.,Ltd.; Hta Co.,Ltd; Jaco Pharmaceuticals Co,ltd; Shanghai Syncor Medicine Corp. Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Radioactive Seeds Source Segmentation Breakdown8 items

Application

Hospital

Cancer Center

Types

Iodinc-125 Seeds Source

Palladium-103 Seeds Source

Iridium-192 Seeds Source

Gold-198 Seeds Source

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: Regulatory mandates for crop irradiation, mature nuclear energy ecosystems, and high adoption of precision farming

Europe: EU-funded agri-tech programs, aging population driving medical isotope demand, and carbon-neutral agriculture policies

Asia Pacific: Demographic pressure for food security, government subsidies for radiation-based crop enhancement, and emerging nuclear power infrastructure

Latin America: Policy shifts toward sustainable farming, cross-border investments in agro-industrial tech, and improving rural electrification

Middle East & Africa: Drought mitigation strategies, public-private partnerships in nuclear research, and demographic-driven healthcare modernization

Competitive Landscape

Best Medical International: global partnerships for R&D collaboration

Eckert & Ziegler: vertical integration in isotope sourcing and manufacturing

BD: expansion of oncology-focused product portfolio

IsoAid: premium pricing for high-purity isotopic solutions

GE Healthcare: localization of production in emerging markets

Shanghai Syncor Medicine Corp.: cost-optimized OEM tie-ups

Key Radioactive Seeds Source Companies10 items

Best Medical International

Eckert & Ziegler

IsoAid

GE Healthcare

Bard Medical

Yantai Dongcheng Biochemicals Co.,Ltd.

Hta Co.,Ltd

Jaco Pharmaceuticals Co,ltd

Shanghai Syncor Medicine Corp. Ltd.

Market Ecosystem

Raw Material Suppliers — provide isotopes (e.g., I-125, Pd-103) and encapsulation materials for seed fabrication

OEMs/Manufacturers — produce seeds using proprietary processes to meet dosimetry and radiological standards

Technology Providers — develop irradiation equipment, encapsulation tools, and quality assurance systems

System Integrators — assemble, test, and calibrate seed components into certified medical devices

Distributors/Channel Partners — manage cold-chain logistics and regulatory compliance during seed delivery

Service Providers — supply post-deployment calibration, safety training, and waste disposal solutions

Regulators/Standards Bodies — enforce production approvals, safety benchmarks, and usage monitoring

Recent Industry Insights

Analyst Overview

Table of Contents